Sandeep Satsangi
Overview
Explore the profile of Sandeep Satsangi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Govil S, Satsangi S, Reddy J, Raghavaiah S, Swaminathan S
Natl Med J India
. 2022 Dec;
35(2):82-87.
PMID: 36461849
Background The western recommendations for the use of organs from liver donors with tuberculosis (TB) come from an environment where the burden of disease is low and cadaveric organ donation...
2.
Satsangi S, Gupta N, Kodan P
J Clin Transl Hepatol
. 2021 Jul;
9(3):436-446.
PMID: 34221930
Corona virus disease (COVID)-19 is caused by the novel severe acute respiratory syndrome coronavirus-2 (commonly referred to as SARS-CoV-2). In March 2020, the World Health Organization declared the COVID-19 outbreak...
3.
Dhiman R, Grover G, Premkumar M, Taneja S, Duseja A, Arora S, et al.
J Hepatol
. 2019 Jul;
71(6):1076-1085.
PMID: 31325468
Background & Aims: The prevalence of anti-hepatitis C virus antibody in Punjab, India is 3.6%, with 728,000 people estimated to have viremic chronic hepatitis C (CHC). The Mukh-Mantri Punjab Hepatitis...
4.
5.
Sakpal M, Satsangi S, Mehta M, Duseja A, Bhadada S, Das A, et al.
JGH Open
. 2018 Nov;
1(2):62-67.
PMID: 30483536
Background And Aim: Deficiency of vitamin D may be related to the pathogenesis of nonalcoholic fatty liver disease (NAFLD). The aim of the present study was to evaluate the effect...
6.
7.
8.
Dhiman R, Grover G, Premkumar M, Taneja S, Duseja A, Rathi S, et al.
J Pediatr Gastroenterol Nutr
. 2018 Sep;
68(1):74-80.
PMID: 30211847
Objectives: We assessed the efficacy of decentralized public health services and safety of direct-acting antiviral agents (DAAs) in the treatment of pediatric chronic hepatitis C (CHC) in the Mukh-Mantri Punjab...
9.
Satsangi S, Duseja A, Sachdeva M, Tomer S, Arora S, Taneja S, et al.
PLoS One
. 2018 Jul;
13(7):e0200644.
PMID: 30020985
Background And Aim: Due to a dysregulated immune response, patients with acute-on-chronic liver failure (ACLF) have increased risk of infection and multi organ failure in comparison to compensated cirrhosis. The...
10.